Cargando…
New options with dabigatran etexilate in anticoagulant therapy
Thrombosis, the localized clotting of blood, occurs in both the arterial and venous circulation, and has a major impact on health outcomes. The primary etiology of myocardial infarctions, and approximately 80% of strokes, is acute arterial thrombosis. In combination this represents the most common c...
Autores principales: | Maegdefessel, Lars, Spin, Joshua M, Azuma, Junya, Tsao, Philip S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879296/ https://www.ncbi.nlm.nih.gov/pubmed/20531953 |
Ejemplares similares
-
Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
por: Bellamy, L, et al.
Publicado: (2009) -
The Discovery of Dabigatran Etexilate
por: van Ryn, Joanne, et al.
Publicado: (2013) -
Dabigatran etexilate tetrahydrate
por: Liu, Hong-Qiang, et al.
Publicado: (2012) -
Adverse events in patients initiated on dabigatran etexilate therapy
in a pharmacist-managed anticoagulation clinic
por: Donaldson, Mark, et al.
Publicado: (2013) -
Dabigatran-etexilate: Lack of efficacy: case report
Publicado: (2021)